Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Delayed Quote USD

Rani Therapeutics Holdings, Inc. (RANI)

Compare
1.1700
+0.0200
+(1.74%)
At close: April 17 at 4:00:00 PM EDT
1.1700
0.00
(0.00%)
After hours: April 17 at 5:37:44 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,028
1,028
--
--
2,717
Operating Expense
50,628
50,628
66,099
63,451
54,316
Operating Income
-49,600
-49,600
-66,099
-63,451
-51,599
Net Non Operating Interest Income Expense
-3,270
-3,270
-1,784
177
-377
Other Income Expense
-3,714
-3,714
--
--
-1,071
Pretax Income
-56,584
-56,584
-67,883
-63,274
-53,047
Tax Provision
--
--
--
70
41
Net Income Common Stockholders
-30,018
-30,018
-33,970
-30,588
-8,331
Diluted NI Available to Com Stockholders
-30,018
-30,018
-33,970
-30,588
-8,331
Basic EPS
-1.05
--
-1.33
-1.28
-0.43
Diluted EPS
-1.05
--
-1.33
-1.28
-0.43
Basic Average Shares
28,476
--
25,505
23,817
19,534
Diluted Average Shares
28,476
--
25,505
23,817
19,534
Total Operating Income as Reported
-53,314
-53,314
-66,099
-63,451
-51,599
Total Expenses
50,628
50,628
66,099
63,451
54,316
Net Income from Continuing & Discontinued Operation
-30,018
-30,018
-33,970
-30,588
-8,331
Normalized Income
-26,304
-26,304
-33,970
-30,588
-7,549.1700
Interest Income
1,763
1,763
3,301
1,248
89
Interest Expense
5,033
5,033
5,085
1,071
466
Net Interest Income
-3,270
-3,270
-1,784
177
-377
EBIT
-51,551
-51,551
-62,798
-62,203
-52,581
EBITDA
-50,523
-50,523
-61,976
-61,655
-52,084
Reconciled Depreciation
1,028
1,028
822
548
497
Net Income from Continuing Operation Net Minority Interest
-30,018
-30,018
-33,970
-30,588
-8,331
Total Unusual Items Excluding Goodwill
-3,714
-3,714
--
--
-1,071
Total Unusual Items
-3,714
-3,714
--
--
-1,071
Normalized EBITDA
-46,809
-46,809
-61,976
-61,655
-51,013
Tax Rate for Calcs
--
--
--
0
0.0003
Tax Effect of Unusual Items
--
--
--
--
-289.1700
12/31/2021 - 7/30/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TNYA Tenaya Therapeutics, Inc.
0.4500
-2.58%
 
ENVB Enveric Biosciences, Inc.
1.1700
-4.88%
 
HOWL Werewolf Therapeutics, Inc.
0.9190
+8.37%
 
IMUX Immunic, Inc.
0.9800
+3.98%
 
INAB IN8bio, Inc.
0.1609
+2.09%
 
BTAI BioXcel Therapeutics, Inc.
1.7400
-4.40%
 
TVGN Tevogen Bio Holdings Inc.
0.9796
-3.96%
 
ALXO ALX Oncology Holdings Inc.
0.5500
-1.79%
 
LIPO Lipella Pharmaceuticals Inc.
2.4000
+0.42%
 
IRD Opus Genetics, Inc.
0.7599
+3.37%